Cell Cure Neurosciences

Cell Cure Neurosciences Ltd. (Cell Cure) is developing cell therapies for retinal and neurodegenerative diseases. Its therapeutic pipeline includes OpRegen™ for retinal diseases and the development of neural progenitor cells for degenerative neurological conditions. Cell Cure's regenerative medicine treatment platform is derived from human embryonic stem cells (hESCs), which are pluripotent cells capable of differentiating into all cell types in the human body.